Furthermore, the disruption of the TROY/RKIP interaction in the glioma cells with the TAT-TROY (234–371 aa) protein decreased both the clonogenic proliferative ability of the glioma cells and the glioma growth in xenografted glioma models. The gene discussed is PEBP1; the disease is central nervous system cancer.